|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5298 USD | +0.02% |
|
+0.02% | +17.73% |
| 06/04 | Zivo Bioscience Inc Signs Manufacturing Agreement with Cyanotech Corporation for Zivolife Algal Biomass | CI |
| 12/11 | Cyanotech Corporation, Q2 2026 Earnings Call, Nov 11, 2025 |
| Market Cap | 2.17M 1.89M 1.76M 1.62M 3.06M 207M 3.09M 20.76M 8.12M 103M 8.17M 7.99M 343M | P/E 2024 |
-0.36x | P/E 2025 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 13.48M 11.71M 10.91M 10.03M 18.96M 1.28B 19.17M 129M 50.3M 641M 50.63M 49.52M 2.12B | EV / Sales 2024 |
0.53x | EV / Sales 2025 | 0.57x |
| Free-Float |
67.23% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Cyanotech Corporation
| 1 day | +0.02% | ||
| 1 week | +0.02% | ||
| 1 month | +8.88% | ||
| 3 months | +36.16% | ||
| 6 months | +12.72% | ||
| Current year | +17.73% |
| 1 month | 0.39 |  | 0.53 |
| Current year | 0.23 | | 0.55 |
| 1 year | 0.21 | | 0.57 |
| 3 years | 0.12 | | 1.02 |
| 5 years | 0.12 | | 3.95 |
| 10 years | 0.12 | | 6.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Custer
CEO | Chief Executive Officer | 43 | 16/06/2022 |
Gerald Cysewski
CEO | Chief Executive Officer | 77 | 31/03/2016 |
| Director of Finance/CFO | 46 | 21/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
David Vied
BRD | Director/Board Member | 65 | 27/01/2015 |
David Mulder
BRD | Director/Board Member | 65 | 17/05/2016 |
Matthew Custer
BRD | Director/Board Member | 43 | 16/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/9/25 | Free | Chief Financial Officer | 50,000 | 0.6987% | ||
| 28/8/25 | Free | Director | 50,000 | 0.6987% | ||
| 28/8/25 | Free | Director | 50,000 | 0.6987% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.02% | +0.02% | +43.19% | -42.97% | 3.84M | |
| +4.89% | -1.90% | +54.98% | +161.43% | 995B | |
| +0.74% | -3.20% | +50.54% | +48.49% | 614B | |
| +1.92% | -6.08% | +24.54% | +64.49% | 431B | |
| +1.62% | +0.33% | +42.09% | +37.02% | 353B | |
| +0.35% | -3.51% | +31.12% | +39.32% | 293B | |
| +2.75% | -8.06% | +7.63% | +10.93% | 245B | |
| +5.89% | +6.46% | +37.53% | +63.16% | 210B | |
| -4.13% | -13.02% | -3.87% | -46.12% | 210B | |
| -1.86% | +0.22% | +18.29% | +64.90% | 168B | |
| Average | +1.28% | -4.52% | +30.60% | +40.06% | 351.82B | |
| Weighted average by Cap. | +2.28% | -5.89% | +37.60% | +73.88% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 23.07M 20.03M 18.68M 17.16M 32.45M 2.19B 32.81M 220M 86.08M 1.1B 86.64M 84.74M 3.63B | 24.22M 21.03M 19.6M 18.01M 34.06M 2.3B 34.43M 231M 90.35M 1.15B 90.93M 88.94M 3.82B |
| Net income | -5.27M -4.57M -4.26M -3.92M -7.41M -501M -7.49M -50.27M -19.65M -250M -19.78M -19.35M -830M | -3.2M -2.78M -2.59M -2.38M -4.51M -305M -4.55M -30.57M -11.95M -152M -12.03M -11.76M -505M |
| Net Debt | 10.2M 8.85M 8.26M 7.58M 14.34M 970M 14.5M 97.33M 38.05M 485M 38.29M 37.45M 1.61B | 11.31M 9.82M 9.15M 8.41M 15.9M 1.08B 16.08M 108M 42.19M 538M 42.46M 41.53M 1.78B |
Employees
83
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- CYAN Stock
Select your edition
All financial news and data tailored to specific country editions
